Who has replaced former market darling Apple (NASDAQ: AAPL ) with this imposter? The world's largest consumer tech company posted a dip in profitability for the first time since 2003, but that wasn't the worst part. Apple's guidance calls for an even bigger hit during the current quarter.
At the same time, former market laughingstock Netflix (NASDAQ: NFLX ) continues its redemptive ascent. Who says that there are no second chances in cyberspace?
Netflix closed out a record quarter where it landed more than 3 million net streaming subscriber additions. The leading video service's outlook was just as encouraging.
That's the way the market goes. Success isn't forever, as Apple investors are finding out. However, failure also doesn't have to be a permanent situation, as Netflix investors are discovering.
Briefly in the news
And now let's take a quick look at some of the other stories that shaped our week.
Cliffs Natural Resources (NYSE: CLF ) moved higher after posting results that may not seem all that inspiring at first. Revenue slipped 6% and adjusted earnings plunged 74% . However, the iron ore pellets producer was expected to each just half as much as it did. After seeing its stock shed nearly roughly half of its value this year, the bounce was more than overdue. Akamai (NASDAQ: AKAM ) also posted better-than-expected results, proving that being a content delivery network doesn't have to be a cutthroat business. J.P. Morgan upgraded Akamai on the strong report. Baidu (NASDAQ: BIDU ) was a rare tech loser on the week, slipping on Friday after posting a quarterly profit that fell well short of Wall Street's forecast. Sometimes even a stock trading at an earnings multiple in the teens yet sporting net profit margins of 34% and growing revenue at a 40% clip isn't good enough.
Matrix Metals Limited is a mineral exploration company. The Company��s Wee MacGregor Project is located approximately 30 kilometers southeast of Mt Isa in Queensland. The Project consists of five granted Exploration Permits for Minerals (EPMs) covering an area of 209 kilometers square and one EPM application covering an area of approximately 19.2 kilometers square. The Inkerman prospect is located on EPM17907 and flanks the old Inkerman workings located on a small Mining Claim in the north (not held by the Company). The Rosebud prospect is located on EPM17449 and surrounds historic Rosebud workings located on a small Mining Lease in the north (not held by the Company). The Copper Cone prospect is located on EPM17449 and is hosted in a tightly folded sequence of the Ballara quartzite. In February 2014, the Company announced that it has completed the acquisition of Caeneus Minerals Pty Ltd.
Advisors' Opinion: Top 5 Integrated Utility Companies For 2015: Bemis Company Inc (BMS)
Bemis Company, Inc., incorporated on May 18, 1885, is a manufacturer of packaging products and pressure sensitive materials. The Company's business activities are organized around its three reportable business segments, U.S. Packaging , Global Packaging and Pressure Sensitive Materials. The majority of the Company��s products are sold to customers in the food industry. Other customers include companies businesses, such as chemical, agribusiness, medical, pharmaceutical, personal care, electronics, automotive, construction, graphic industries and other consumer goods. In July 2013, Bemis Company Inc acquired all of the common stock of Foshan New Changsheng Plastics Films Co., LTD.
The Company��s flexible packaging businesses has a technical base in polymer chemistry, film extrusion, coating, laminating, printing, and converting. The Company��s pressure sensitive materials business specializes in adhesive technologies. On August 22, 2012, the Company acquired two flexible packaging businesses in Australia and New Zealand.
U.S. Packaging segment
The U.S. Packaging segment represents all food, consumer, and industrial products packaging-related manufacturing operations located in the United States. This segment manufactures multilayer polymer, blown and cast film structures to produce packaging sold for food and personal care product applications as well as non-food applications. Additional products include custom thermoformed packaging, and multiwall paper bags. Markets for these products include processed and fresh meat, liquids, frozen foods, cereals, snacks, cheese, coffee, condiments, candy, pet food, bakery, seed, lawn and garden, tissue, fresh produce, personal care and hygiene, disposable diapers, agribusiness, and minerals. This segment has 35 manufacturing plants located in 16 states, of which 32 are owned directly by the Company or its subsidiaries and three are leased from outside parties.
Global Packaging segment
The ! Global Packaging segment includes all packaging-related manufacturing operations located outside of the United States as well as global medical device and pharmaceutical packaging manufacturing operations. This segment manufactures multilayer polymer, blown and cast film structures to produce packaging sold for a variety of food, medical, pharmaceutical, personal care, and industrial applications. Additional products include injection molded plastic and folding carton packaging. Markets for these products include processed and fresh meat, liquids, snacks, cheese, coffee, condiments, candy, bakery, tissue, fresh produce, personal care and hygiene, disposable diapers, agribusiness, pharmaceutical, and medical devices. This segment has 32 manufacturing plants located in three United States, the Commonwealth of Puerto Rico, and ten non-United States countries, of which 26 are owned directly by the Company or its subsidiaries and six are leased from outside parties.
Pressure Sensitive Materials segment
The Pressure Sensitive Materials segment is a global manufacturer of pressure sensitive adhesive coated paper and film substrates sold into label, graphic, and technical product markets. Products for label markets include narrow-Web rolls of pressure sensitive paper, film, and metalized film printing stocks used in high-speed printing and die-cutting. Products for graphic markets include pressure sensitive films used for decorative signage through computer-aided plotters, digital and screen printers, and photographic overlaminate and mounting materials including optically clear films with built-in ultraviolet (UV) inhibitors. Products for technical markets include micro-thin film adhesives used in delicate electronic parts assembly and pressure sensitive applications utilizing foam and tape based stocks to perform fastening and mounting functions. This segment has seven manufacturing plants located in three states and two non-United States countries, all of which are owned directly b! y the Com! pany or its subsidiaries.
The Company competes with Amcor Limited, Berry Plastics Corporation, Bryce Corporation, Exopack Company, Hood Packaging Corporation, Printpack, Inc., Sealed Air Corporation, Sonoco Products Company, Wihuri OY, Winpak ltd, 3M, Acucote, Inc., Avery Dennison Corporation, FLEXcon Corporation, Green Bay Packaging Inc., Ricoh Company, Ltd., Ritrama Inc., Spinnaker Industries, Inc., Technicote Inc., UPM-Kymmene Corporation, and Wausau Coated Products Inc.
Advisors' Opinion: - [By Jessica Alling]
Leaders and laggards
Merck (NYSE: MRK ) is at the top of the class this morning with a 5.19% gain following some extremely encouraging news about its latest experimental drug,�lambrolizumab. Aimed at unleashing the powers of a patient's own immune system, the drug disables the immune system cells' prevention method that curbs its attack on cancer cells -- a protein called the programmed death 1 receptor, or PD-1. Merck's drug has shown a 38% rate in tumor reduction in patients with advanced melanoma, and up to 52% in patients who received the highest dosage of the drug. Though the patients have not undergone the trial for a long enough period yet, the results are attracting attention for matching the current treatments from two Bristol-Meyers Squibb (NYSE: BMS ) drugs, Yervoy and nivolumab, with potentially milder side effects. The news is great for Merck investors, as the company has only played a small part in oncology treatments to date.
- [By Rich Duprey]
Looking to increase its presence and market share in Asia, specialty packaging maker Bemis (NYSE: BMS ) announced today it was acquiring a Chinese manufacturer of specialty films, Foshan New Changsheng Plastics Films.�
- [By The Part-time Investor]
The following stocks met the criteria in January of 2008 and were put into the initial portfolio:
Abbot Labs (ABT)Advanced data processing (ADP)Associated Banc-Corp (ASBC)Bank of America (BAC)BB&T Corp. (BBT)Bemis Company (BMS)Anheuser Busch (BUD)The Chubb Corporation (CB)Clorox (CLX)Comerica Inc. (CMA)Diebold Inc. (DBD)Emerson Electronics (EMR)First Dollar Corp. (FDO)First Third BanCorp. (FITB)Gannett Co, Inc. (GCI)General Electric (GE)Hershey (HSY)Illinois Tools Works (ITW)Johnson and Johnson (JNJ)Leggett and Platt (LEG)Eli Lilly (LLY)La-Z-Boy (LZB)McDonald's (MCD)Marsh and Ilsley (MI)M&T Bancorp (MTB)PepsiCo (PEP)Pfizer (PFE)Procter & Gamble (PG)Pentair Ltd. (PNR)Regions Financial Corp. (RF)Rohm and Haas (ROH)RPM International (RPM)Sherwin Williams (SHW)Sysco Corp. (SYY)UDR Inc. (UDR)Historical quotes were taken from Yahoo Finance. $10,000 was put into each position, to the nearest whole share, so a total of $349,262.89 was invested. From 1/15/08 through 5/16/13 all dividends were reinvested back into the stock that paid them. If a dividend cut was announced, that stock was sold on the ex-div date of the new, lower dividend.
Top 5 Integrated Utility Companies For 2015: iShares J.P. Morgan USD Emerging Markets Bond ETF (EMB)
iShares JPMorgan USD Emerging Markets Bond Fund (the Fund) is a non-diversified fund. The investment objective of the Fund is to provide investment results that correspond generally to the price and yield performance of a specified benchmark index (the Underlying Index) representing a segment of emerging countries bond markets. The Fund seeks to achieve its objective by investing primarily in fixed-income securities that comprise the Underlying Index. The Fund operates as an index fund and will not be actively managed. The adverse performance of a security in the Fund��s portfolio will ordinarily not result in the elimination of the security from the Fund��s portfolio. The Fund is managed by Barclays Global Fund Advisors (BGFA), a subsidiary of iShares JPMorgan USD Emerging Markets Bond Fund (BGI).
The Fund generally will invest at least 90% if its assets in the securities of its Underlying Index. However, the Fund may at times invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, including money market funds advised by BGFA, as well as in high-yield corporate bonds not included in its Underlying Index. iShares JPMorgan USD Emerging Markets Bond Fund invests a substantial portion of its assets in the United States-denominated bonds issued by sovereign and quasi-sovereign entities of emerging market countries. The Fund may invest in short-term instruments, including money market instruments, on an ongoing basis to provide liquidity or for other reasons.
Advisors' Opinion: - [By Saumya Vaishampayan]
The iShares J.P. Morgan USD Emerging Markets Bond Exchange-Traded Fund (EMB) fell 0.6% to end at $107.55. �
- [By Dan Caplinger]
Finally, beyond the Dow, the real damage is happening not in stocks but in other markets, especially bonds. PIMCO Total Return ETF (NYSEMKT: BOND ) is down 1.3%, proving to investors seeking safety that bond investments are far from a secure place to put your money these days. Emerging-market bond investments are taking even more damage, with iShares JPMorgan USD Emerging Markets Bond (NYSEMKT: EMB ) plunging 3.5%. When investors try to reduce their risk, the first place they look is in the more aggressive areas where they've put their money. The exodus from emerging markets in both stocks and bonds shows the fear that's rising among U.S. investors -- but that fear is motivated less by the prospects in those countries than by investors' desire to preserve hard-won profits dating back to 2009.
Top 5 Integrated Utility Companies For 2015: Sangamo BioSciences Inc.(SGMO)
Sangamo Biosciences, Inc. engages in the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP transcription factors (ZFP TFs), proteins that could be used to turn genes on or off; and ZFP nucleases (ZFNs), proteins that enable to modify DNA sequences in various ways. The company?s principal ZFP therapeutic include SB-509, a plasmid formulation of a ZFP TF activator of the vascular endothelial growth factor-A (VEGF-A) gene that is in a Phase 2b clinical trial for the treatment of severe diabetic neuropathy; and in a Phase 2 clinical trial in for the treatment of amyotrophic lateral sclerosis, as well as in preclinical animal studies for spinal cord injury, traumatic brain injury, and stroke. It is also developing SB-728-T, a ZFN-modified T-cell product, which is in Phase 1/2 clinical trial and two Phase 1 trials for the treatment of HI V/AIDS. In addition, the company develops SB-313xTZ, a ZFN-based therapeutic that is in Phase 1 clinical trial for the treatment of glioblastoma multiforme, a type of brain cancer. Further, it has preclinical development programs of ZFP therapeutics in the areas of Parkinson?s disease, hemophilia B, and neuropathic pain; and neuroregenerative programs in spinal cord injury, traumatic brain injury, and stroke. Additionally, the company has research stage programs in the areas of monogenic diseases and genetic conditions that result from a defect in a single gene, including hemophilia and other hemoglobinopathies, and immunodeficiencies. It has collaboration agreements with Sigma-Aldrich Corporation; Dow AgroSciences LLC; Pfizer Inc.; Genentech, Inc.; Open Monoclonal Technology, Inc.; and F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. The company was founded in 1995 and is headquartered in Richmond, California.
Advisors' Opinion: